| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Carola Seifart | |
| Alexandra Plagens | |||
| P2860 | cites work | Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history | Q24678654 |
| Functional variants of antioxidant genes in smokers with COPD and in those with normal lung function | Q24681700 | ||
| Role of transforming growth factor beta in human disease | Q28143408 | ||
| The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function | Q28204710 | ||
| Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary | Q29614692 | ||
| Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper | Q29614960 | ||
| Genome-wide association studies for common diseases and complex traits | Q29615822 | ||
| Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study | Q30790513 | ||
| Proteases and antiproteases | Q31994482 | ||
| Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. | Q32008846 | ||
| Genes, oxidative stress, and the risk of chronic obstructive pulmonary disease | Q33588119 | ||
| Matrix metalloproteinases. Matrix degradation and more | Q33643000 | ||
| Oxidants/antioxidants and COPD. | Q33937680 | ||
| Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice | Q34008084 | ||
| The SERPINE2 gene is associated with chronic obstructive pulmonary disease | Q34398902 | ||
| Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema | Q34457903 | ||
| Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease | Q34521964 | ||
| Genome-wide association studies: theoretical and practical concerns | Q34555195 | ||
| COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity | Q34637487 | ||
| Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity--a common inflammatory phenotype? | Q34684222 | ||
| Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema | Q34742826 | ||
| Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis | Q34743595 | ||
| The genetics of chronic obstructive pulmonary disease. | Q35113365 | ||
| Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage | Q35113482 | ||
| Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1. | Q35533626 | ||
| Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis | Q35536217 | ||
| Chronic obstructive pulmonary disease: definition and epidemiology | Q35598823 | ||
| Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation | Q36082965 | ||
| Genetic approaches to studying common diseases and complex traits | Q36092154 | ||
| Inflammatory cells in the airways in COPD. | Q36203075 | ||
| An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles | Q36361285 | ||
| Global impact of COPD. | Q36361775 | ||
| Polymorphisms for microsomal epoxide hydrolase and genetic susceptibility to COPD. | Q36995133 | ||
| Genetic determinants of functional impairment in chronic obstructive pulmonary disease. | Q37109275 | ||
| Genetic association analysis of functional impairment in chronic obstructive pulmonary disease | Q37144319 | ||
| Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations | Q37273821 | ||
| Surfactant protein B intron 4 variation in German patients with COPD and acute respiratory failure | Q37364180 | ||
| Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease | Q38293558 | ||
| An IL-13 promoter polymorphism associated with increased risk of allergic asthma | Q38303909 | ||
| Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer | Q38474281 | ||
| Household aggregation of pulmonary function and chronic bronchitis | Q39219478 | ||
| The Pi system-inherited variants of serum alpha 1-antitrypsin | Q39990142 | ||
| Family study of alpha 1-antitrypsin deficiency: effects of cigarette smoking, measured genotype, and their interaction on pulmonary function and biochemical traits | Q41131958 | ||
| Experimental neonatal respiratory failure induced by a monoclonal antibody to the hydrophobic surfactant-associated protein SP-B. | Q41665986 | ||
| Assessment of genetic and nongenetic influences on pulmonary function. A twin study | Q42661793 | ||
| Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease | Q43826358 | ||
| Antioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokers | Q44086877 | ||
| Possible protective effect against chronic obstructive airways disease by the GC2 allele | Q44418780 | ||
| Vitamin D binding protein variants and the risk of COPD. | Q44649090 | ||
| Emphysema lung tissue gene expression profiling | Q44799070 | ||
| The transforming growth factor-beta1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD). | Q47401096 | ||
| TNF-alpha-, TNF-beta-, IL-6-, and IL-10-promoter polymorphisms in patients with chronic obstructive pulmonary disease | Q47861678 | ||
| A leucine-to-proline substitution causes a defective alpha 1-antichymotrypsin allele associated with familial obstructive lung disease | Q48104043 | ||
| Variance components analysis of forced expiration in families | Q49195950 | ||
| Z and S mutations of the alpha1-antitrypsin gene and the risk of chronic obstructive pulmonary disease | Q50537813 | ||
| Segregation analysis of pulmonary function among families in the Framingham Study. | Q50885975 | ||
| Peculiarities of the GSTM1 0/0 genotype in French heavy smokers with various types of chronic bronchitis. | Q50951067 | ||
| A genome-wide scan of pulmonary function measures in the National Heart, Lung, and Blood Institute Family Heart Study. | Q51682107 | ||
| Genome-wide linkage analysis of severe, early-onset chronic obstructive pulmonary disease: airflow obstruction and chronic bronchitis phenotypes. | Q51722853 | ||
| Gene expression profiling of human lung tissue from smokers with severe emphysema. | Q51989419 | ||
| Association of tumor necrosis factor-alpha gene promoter polymorphism with low attenuation areas on high-resolution CT in patients with COPD. | Q53673910 | ||
| Studies in alpha 1-antitrypsin deficiency. | Q54285259 | ||
| Genomic DNA pooling for whole-genome association scans in complex disease: empirical demonstration of efficacy in rheumatoid arthritis | Q54330502 | ||
| Letter: Natural history of chronic bronchitis | Q55138796 | ||
| Genetic Loci Influencing Lung Function | Q57319313 | ||
| α1-Antitrypsin TAQ I polymorphism and α1-antichymotrypsin mutations in patients with obstructive pulmonary disease | Q58885905 | ||
| Chronic obstructive pulmonary disease is associated with the -1055 IL-13 promoter polymorphism | Q61601313 | ||
| Familial occurrence of chronic respiratory disease and familial resemblance in ventilatory capacity | Q66923385 | ||
| Expression of pulmonary cytochrome P4501A1 and carcinogen DNA adduct formation in high risk subjects for tobacco-related lung cancer | Q67972988 | ||
| DNA polymorphisms of the alpha 1-antitrypsin gene region in patients with chronic obstructive pulmonary disease | Q68085115 | ||
| Epidemiology of chronic obstructive pulmonary disease | Q68541473 | ||
| Major genetic mechanisms in pulmonary function | Q68854194 | ||
| Familial factors related to lung function in children aged 6-10 years. Results from the PAARC epidemiologic study | Q69623835 | ||
| Genetic and environmental influences on pulmonary function in adult twins | Q70675879 | ||
| Smoking and lung function | Q70783787 | ||
| Segregation analysis of two lung function indices in a random sample of young families: the Humboldt Family Study | Q71118714 | ||
| Family aggregation of pulmonary function measurements | Q71288392 | ||
| Genetic and Environmental Determinants of Chronic Obstructive Pulmonary Disease | Q71514944 | ||
| Decreased lung compliance and air trapping in heterozygous SP-B-deficient mice | Q71980262 | ||
| Surfactant protein B corrects oxygen-induced pulmonary dysfunction in heterozygous surfactant protein B-deficient mice | Q73254058 | ||
| Microsomal epoxide hydrolase genotypes and chronic obstructive pulmonary disease in Japanese | Q73280601 | ||
| Association of tumor necrosis factor alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease | Q73442209 | ||
| Susceptibility genes for rapid decline of lung function in the lung health study | Q73442228 | ||
| Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population | Q74598084 | ||
| HEREDITARY DEFICIENCY OF SERUM ALPHA-L-ANTITRYPSIN | Q76996816 | ||
| Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema | Q77171691 | ||
| Formation and structure of surface films: captive bubble surfactometry | Q77545836 | ||
| Genetic control of the circulating concentration of transforming growth factor type beta1 | Q77789926 | ||
| Genome-wide linkage of forced mid-expiratory flow in chronic obstructive pulmonary disease | Q80526285 | ||
| Genetic polymorphism in matrix metalloproteinase-9 and the susceptibility to chronic obstructive pulmonary disease in Han population of south China | Q80893659 | ||
| P433 | issue | 4 | |
| P921 | main subject | chronic obstructive pulmonary disease | Q199804 |
| P304 | page(s) | 541-550 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | International Journal of Chronic Obstructive Pulmonary Disease | Q6051335 |
| P1476 | title | Genetics of chronic obstructive pulmonary disease | |
| P478 | volume | 2 |
| Q34335599 | Analyses of association between PPAR gamma and EPHX1 polymorphisms and susceptibility to COPD in a Hungarian cohort, a case-control study. |
| Q58737099 | Cigarette smoke exposure decreases CFLAR expression in the bronchial epithelium, augmenting susceptibility for lung epithelial cell death and DAMP release |
| Q64229538 | Effect of the thymine-DNA glycosylase rs4135050 variant on Saudi smoker population |
| Q45894876 | Functional characterization of a porcine emphysema model |
| Q55425332 | Genetic profile and patient-reported outcomes in chronic obstructive pulmonary disease: A systematic review. |
| Q89849229 | High Serum Level of IL-17 in Patients with Chronic Obstructive Pulmonary Disease and the Alpha-1 Antitrypsin PiZ Allele |
| Q86573040 | Identification of FAM13A gene associated with the ratio of FEV1 to FVC in Korean population by genome-wide association studies including gene-environment interactions |
| Q37168317 | Markers of early disease and prognosis in COPD. |
| Q24650256 | PTEN identified as important risk factor of chronic obstructive pulmonary disease |
| Q54313332 | Surfactant protein a polymorphism is associated with susceptibility to chronic obstructive pulmonary disease in Chinese Uighur population. |
| Q60915889 | The Aryl Hydrocarbon Receptor and the Maintenance of Lung Health |
| Q47138266 | Tobacco-smoking induced GPR15-expressing T cells in blood do not indicate pulmonary damage |
Search more.